Literature DB >> 24258487

New intriguing roles of ATP and its receptors in promoting tumor metastasis : presented by Maria P. Abbracchio.

Elena Adinolfi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24258487      PMCID： PMC3889383          DOI： 10.1007/s11302-013-9401-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN： 1573-9538            Impact factor:   3.765


× No keyword cloud information.
  16 in total

1.  Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor.

Authors:  Elena Adinolfi; Maria Cirillo; Ronja Woltersdorf; Simonetta Falzoni; Paola Chiozzi; Patrizia Pellegatti; Maria Giulia Callegari; Doriana Sandonà; Fritz Markwardt; Günther Schmalzing; Francesco Di Virgilio
Journal:  FASEB J       Date:  2010-05-07       Impact factor: 5.191

2.  P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness.

Authors:  B Jelassi; A Chantôme; F Alcaraz-Pérez; A Baroja-Mazo; M L Cayuela; P Pelegrin; A Surprenant; S Roger
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

Review 3.  Tumor-platelet interaction in solid tumors.

Authors:  Daniel Buergy; Frederik Wenz; Christoph Groden; Marc A Brockmann
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

4.  Expression of P2X7 receptor increases in vivo tumor growth.

Authors:  Elena Adinolfi; Lizzia Raffaghello; Anna Lisa Giuliani; Luigi Cavazzini; Marina Capece; Paola Chiozzi; Giovanna Bianchi; Guido Kroemer; Vito Pistoia; Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

5.  Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.

Authors:  Fumie Hattori; Yasuhiro Ohshima; Shizuka Seki; Mitsutoshi Tsukimoto; Mitsuru Sato; Takato Takenouchi; Akina Suzuki; Erina Takai; Hiroshi Kitani; Hitoshi Harada; Shuji Kojima
Journal:  Eur J Pharmacol       Date:  2012-09-11       Impact factor: 4.432

6.  Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.

Authors:  Dagmar Schumacher; Boris Strilic; Kishor Kumar Sivaraj; Nina Wettschureck; Stefan Offermanns
Journal:  Cancer Cell       Date:  2013-06-27       Impact factor: 31.743

Review 7.  The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review).

Authors:  Wei-Tian Wei; Sheng-Zhang Lin; Dian-Lei Liu; Zhao-Hong Wang
Journal:  Oncol Rep       Date:  2013-09-19       Impact factor: 3.906

8.  P2X7 Receptor Function in Bone-Related Cancer.

Authors:  Elena Adinolfi; Francesca Amoroso; Anna Lisa Giuliani
Journal:  J Osteoporos       Date:  2012-08-16

9.  P2X(7) receptor: Death or life?

Authors:  Elena Adinolfi; Cinzia Pizzirani; Marco Idzko; Elisabeth Panther; Johannes Norgauer; Francesco Di Virgilio; Davide Ferrari
Journal:  Purinergic Signal       Date:  2005-07-29       Impact factor: 3.765

10.  The P2X7 receptor is a key modulator of aerobic glycolysis.

Authors:  F Amoroso; S Falzoni; E Adinolfi; D Ferrari; F Di Virgilio
Journal:  Cell Death Dis       Date:  2012-08-16       Impact factor: 8.469
View more
  3 in total

1.  Purinergic control of lysenin's transport and voltage-gating properties.

Authors:  Sheenah Bryant; Nisha Shrestha; Paul Carnig; Samuel Kosydar; Philip Belzeski; Charles Hanna; Daniel Fologea
Journal:  Purinergic Signal       Date:  2016-06-18       Impact factor: 3.765

2.  Sustained Ca2+ mobilizations: A quantitative approach to predict their importance in cell-cell communication and wound healing.

Authors:  Yoonjoo Lee; Min Tae Kim; Garrett Rhodes; Kelsey Sack; Sung Jun Son; Celeste B Rich; Vijaya B Kolachalama; Christopher V Gabel; Vickery Trinkaus-Randall
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

3.  P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin.

Authors:  Ying Qiu; Yan Liu; Wei-Hua Li; Hong-Quan Zhang; Xin-Xia Tian; Wei-Gang Fang
Journal:  Oncol Rep       Date:  2017-11-07       Impact factor: 3.906
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.